FDA Guidance Explains Enforcement Discretion Related to FSMA Provisions

The FDA announced on Jan. 4, 2018, that it intends to exercise enforcement discretion for certain provisions in four of the rules that implement the FDA Food Safety Modernization Act (FSMA). This means that during the enforcement discretion period, the agency does not intend to enforce these provisions as they currently apply to certain entities or activities. AIB's analysis on the the Jan. 4 announcement is that facilities must be prepared despite this message from the FDA. 

With more ways of preparing for FSMA, food facility workers have options that range from in person seminars, PCQI training, FSMA gap assessments, and online training. Have a group to train? The HACCP Integration for FSMA Compliance course is also offered as a private training. Bundle with the FSPCA Preventive Controls for Human Foods course, with an FDA Preparedness Inspection, or with your FSMA Readiness Assessment to maximize your learning experience. 

The enforcement discretion pertains to specific provisions in the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food rule (PC Human Food), Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals rule (PC Animal Food), Foreign Supplier Verification Programs rule (FSVP), and Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption rule (Produce Safety) and how they apply to:

• facilities that would be farms except for certain factors and activities
• written assurances provisions in all four rules related to the control of identified hazards or microorganisms that are a potential risk to public health 
• the animal food preventive controls requirements for certain manufacturing/processing activities performed on human food by-products used as animal food
• FSVP requirements for importers of food contact substances

In general, the FDA is exercising enforcement discretion to allow time to consider changes or other approaches to address concerns regarding the application of these provisions to certain activities or entities. 

FDA had previously extended the compliance dates for many of the provisions covered by this enforcement discretion guidance (see August 2016 compliance date extension) but is now exercising enforcement discretion. 

For more information please see the fact sheet, constituent update, and guidance available at FDA.gov.